Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain

Neuroscience

Volumn 91, Issue 4, 1999, Pages 1483-1497

  Sluck, J M ^a   Lin, R C S ^a   Katolik, L I ^a   Jeng, A Y ^b   Lehmann, J C ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cardiovascular regulation; Cerebrovasculature; Endothelin; Neurope ptides; Receptor

Indexed keywords

ACETYLCHOLINE; BIOGENIC AMINE; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN CONVERTING ENZYME;

ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL STRUCTURE; ENZYME ANALYSIS; FEMALE; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

ANIMALS; ASPARTIC ENDOPEPTIDASES; BLOOD VESSELS; BRAIN; CEREBRAL VENTRICLES; CEREBROVASCULAR CIRCULATION; CHOROID PLEXUS; ENDOTHELIN-1; ENDOTHELIN-3; IMMUNOLOGIC TECHNIQUES; MALE; METALLOENDOPEPTIDASES; RATS; RATS, WISTAR; SPINAL CORD; TISSUE DISTRIBUTION;

EID: 0032958254     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00692-7     Document Type: Article

References (62)

1. Ando K., Hirata Y., Shichiri M., Emori T., Marumo F. Presence of immunoreactive endothelin in human plasma. Fedn Eur. biochem. Socs Lett. 245:1989;164-166.
2. Armstead W.M. Role of endothelin in pial artery vasoconstriction and altered response to vasopressin after brain injury. J. Neurosurg. 85:1996;901-907.
3. Barnes K., Shimada K., Takahashi M., Tanzawa K., Turner A.J. Metallopeptidase inhibitors induce an up-regulation of endothelin-coverting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment. J. Cell Sci. 109:1996;919-928.
4. Barone F.C., Globus M.Y., Price W.J., White R.F., Storer B.L., Feuerstein G.Z., Busto R., Ohlstein E.H. Endothelin levels increase in rat focal and global ischemia. J. cerebr. Blood Flow Metab. 14:1994;337-342.
5. Battistini B., Botting T., Warner T.D. Endothelin: a knockout in London. Trends pharmac. Sci. 16:1995;217-221.
6. Brattström A., Sonntag M., Listing H., Miller R., DeJong W. Neuropeptides within the nucleus tractus solitarii modulate the central cardiovascular control process. Prog. Brain Res. 91:1992;75-79.
7. Calderon E., Gomez-Sanchez C.E., Cozza E.N., Zhou M., Coffey R.G., Lockey R.F., Prockop L.D., Szentivanyi A. Modulation of endothelin-1 production by a pulmonary epithelial cell line I. Regulation by glucocorticoids. Biochem. Pharmac. 48:1994;2065-2071.
8. Calogero A.E., Raiti F., Nicolosi G., Burrello N., D'Agata R.D., Matero F. Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitro. J. Endocr. 140:1994;419-424.
9. Caner H.H., Kwan A.L., Arthur A., Jeng A.Y., Lappe R.W., Kassell N.F., Lee K.S. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasms following experimental subarachnoid hemorrhage. J. Neurosurg. 85:1996;917-922.
10. Chen W.Y., Wang J.Y. Decreased production of endothelin-1 in asthmatic children after immunotherapy. J. Asthma. 32:1995;29-35.
11. Chew B.H., Weaver D.F., Gross P.M. Dose-related potent brain stimulation by the neuropeptide endothelin-1 after intraventricular administration in conscious rats. Pharmac. Biochem. Behav. 51:1995;37-47.
12. Cintra A., Fuxe K., Anggard E., Tinner B., Staines W., Agnati L.F. Increased endothelin-like immunoreactivity in ibotenic acid-lesioned hippocampal formation of the rat brain. Acta physiol. scand. 137:1989;557-558.
13. Cornet S., Pirotzky E., Braquet P. Implication of different endothelin receptors in the vascular action of a hypertensive dose of endothelin-1 in rat. J. cardiovasc. Pharmac. 22:1993;S239-S242.
14. del Basso P., Argiolas L. Cardiopulmonary effects of endothelin-1 in the guinea pig: role of thrombozane A2. J. cardiovasc. Pharmac. 26(Suppl. 3):1995;S120-S122.
15. Deschepper C.F., Houweling A.D., Picard S. The membranes of cultured rat brain astrocytes contain endothelin-converting enzyme activity. Eur. J. Pharmac. 275:1995;61-66.
16. Emoto N., Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J. biol. Chem. 270:1995;15,262-15,268.
17. Furukawa K., Saleh D., Bayan F., Emoto N., Kaw S., Yanagisawa M., Giaid A. Co-expression of endothelin-1 and endothelin-converting enzyme-1 in patients with chronic rhinitis. Am. J. Respir. Cell molec. Biol. 14:1996;248-253.
18. Gajkowska B., Mossakowski M.J. Localization of endothelin in the blood-brain interphase in rat hippocampus after global cerebral ischemia. Folia neuropath. 33:1995;221-230.
19. Giaid A., Gibson S.J., Herrero M.T., Gentleman S., Legon S., Yanagisawa M., Masaki T., Ibrahim N.B., Roberts G.W., Rossi M.L. Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry. 95:1991;303-314.
20. Giaid A., Gibson S.J., Ibrahim B.N., Legon S., Bloom S.R., Yanagisawa M., Masaki T., Varndell I.M., Polak J.M. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc. natn. Acad. Sci. U.S.A. 86:1989;7634-7638.
21. Giuffrida R., Bellomo M., Polizzi G., Malatino L.S. Ischemia-induced changes in the immunoreactivity for endothelin and other vasoactive peptides in the brain of the mongolian gerbil. J. cardiovasc. Pharmac. 20:1992;S41-S44.
22. Golfman L.S., Hata T., Beamish R.E., Dhalla N.S. Role of endothelin in heart function in health and disease. Can. J. Cardiol. 9:1993;635-653.
23. Greenberg D.A., Chan J., Sampson H.A. Endothelins and the nervous system. Neurology. 42:1992;25-31.
24. Gross P.M., Beninger R.J., Shaver S.W., Wainman D.S., Espinosa F.J., Weaver D.F. Metabolic and neuroanatomical correlates of barrel-rolling and oculoclonic convulsions induced by intraventricular endothelin-1: a novel peptidergic signaling mechanism in visuovestibular and oculomotor regulation. Expl Brain Res. 95:1993;397-408.
25. A-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats. Neuropharmacology. 33:1994;1155-1166.
26. Gulati A., Kumar A., Shahani B.T. Cardiovascular effects of centrally administered endothelin-1 and its relationship to changes in cerebral blood flow. Life Sci. 58:1996;437-445.
27. Hashim M.A., Tadepalli A.S. Hemodynamic responses evoked by endothelin from central cardiovascular neural substrates. Am. J. Physiol. 262:1992;H1-H9.
28. Hirata Y., Matsunaga T., Ando K., Furukawa T., Tsukagoshi H., Marumo F. Presence of endothelin-1-like immunoreactivity in human cerebrospinal fluid. Biochem. biophys. Res. Commun. 166:1990;1274-1278.
29. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. natn. Acad. Sci. U.S.A. 86:1989;2863-2867.
30. Jiang M.H., Hoog A., Ma K.C., Nie X.J., Olsson Y., Zhang W.W. Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes. NeuroReport. 4:1993;935-937.
31. Jones C.R., Hiley C.R., Pelton J.T., Mohr M. Autoradiographic visualization of the binding sites for [125I]endothelin in rat and human brain. Neurosci. Lett. 97:1989;276-279.
32. Koizumi S., Kataoka Y., Niwa M., Kumakura K. Endothelin-3 stimulates the release of catecholamine from cortical and striatal slices of the rat. Neurosci. Lett. 134:1992;219-222.
33. Koizumi S., Kataoka Y., Niwa M., Watanabe S., Taniyama K. Two distinct pathways are involved in the endothelin-3-evoked dopamine release from rat striatal slices. Eur. J. Pharmac. 259:1994;159-201.
34. Koseki C., Imai Y., Hirata Y., Yanagisawa M., Masakai T. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am. J. Physiol. 256:1989;R858-R866.
35. Kurihara M., Ochi A., Kawaguchi T., Niwa M., Kataoka Y., Mori K. Localization and characterization of endothelin receptors in human gliomas: a growth factor? Neurosurgery. 27:1990;275-281.
36. Lee M.-E., de la Monte S.M., Ng S.-C., Bloch K.D., Quertermous T. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J. clin. Invest. 86:1990;141-147.
37. Lowenstein D.H., Thomas M.J., Smith D.H., McIntosh T.K. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12:1992;4846-4853.
38. Ma K.C., Nie X.J., Hoog A., Olsson Y., Zhang W.W. Reactive astrocytes in viral infections of the human brain express endothelin-like immunoreactivity. J. neurol. Sci. 126:1994;184-192.
39. MacCumber M., Ross C.A., Snyder H. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc. natn. Acad. Sci. U.S.A. 87:1990;2359-2363.
40. Matsuyama T., Tsuchiyama M., Nakamura H., Matsumoto M., Sugita M. Hilar somatostatin neurons are more vulnerable to an ischemic insult than CA1 pyramidal neurons. J. cerebr. Blood Flow Metab. 13:1993;229-234.
41. Miller R.C., Pelton J.T., Huggins J.P. Endothelins - from receptors to medicine. Trends pharmac. Sci. 14:1993;54-60.
42. Mosqueda-Garcia R., Fernandez-Violante R., Hamakubo T., Stainback R. Vasopressin mediates the pressor effects of endothelin in the subfornical organ of the rat. J. Pharmac. exp. Ther. 277:1996;1034-1042.
43. Mosqueda-Garcia R., Stainback R., Fernandez-Violante R., Hamakubo T. Cardiovascular effects of endothelin injected into brain nuclei regulation vasopressin release. J. cardiovasc. Pharmac. 26:1995;S159-S162.
44. Mosqueda-Garcia R.S., Inagami T., Appalsamy M., Sugiura M., Robertson R.M. Endothelin as a neuropeptide: cardiovascular effects in the brainstem of normotensive rats. Circulation Res. 72:1992;20-35.
45. Nie X.J., Olsson Y. Endothelin peptides in brain diseases. Rev. Neurosci. 7:1996;177-186.
46. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmac. Rev. 46:1994;325-415.
47. Saito A., Shiba R., Kimura S., Yanagisawa M., Goto K., Masaki T. Vasoconstrictor response of large cerebral arteries of cats to endothelin, an endothelium-derived vasoactive peptide. Eur. J. Pharmac. 162:1989;353-358.
48. Shimada K., Takahashi M., Ikeda M., Tanzawa K. Identification and characterization of two isoforms of an endothelin-converting enzyme-1. Fedn Eur. biochem. Socs Lett. 371:1995;140-144.
49. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 235:1987;73-76.
50. Smith D.H., Soares H.D., Pierce J.S., Perlman K.G., Saatman K.E., Meaney D.F., Dixon C.E., McIntosh T.K. A model of parasagittal controlled cortical impact in the mouse: cognitive and histopathologic effects. J. Neurotrauma. 12:1995;169-178.
51. Soares H.D., Hicks R.R., Smith D., McIntosh T.K. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J. Neurosci. 15:1995;8223-8233.
52. Stojilkovic S.S., Catt K.J. Neuroendocrine actions of endothelins. Trends pharmac. Sci. 13:1992;385-391.
53. Tadepalli A.S., Hashim M.A. Mechanisms of central endothelin-induced hypotension. Naunyn-Schmiedeberg's Arch. Pharmac. 352:1995;108-112.
54. Tayag E.C., Katolik L.I., Lin R.C.S., Nair S.N., Jeng A.Y., Yanagisawa M., Lehmann J.C. Endothelin-1 and endothelin converting enzyme-1 following experimental traumatic brain injury in the rat. J. Neurotrauma. 12:1995;992.
55. Wall K.M., Ferguson A.V. Endothelin acts at the subfornical organ to influence the activity of putative vasopressin and oxytocin-secreting neurons. Brain Res. 586:1992;111-116.
56. Xu D., Emoto N., Giaid A., Slaughter C., deWit D., Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell. 78:1994;473-485.
57. Yamamoto S., Inenaga K., Eto S., Yamashita H. Cardiovascular-related peptides influence hypothalamic neurons involved in control of body water homeostasis. Obes. Res. 3(Suppl. 5):1995;789S-794S.
58. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
59. Yoo B. H., Jeng A. Y., Latib N., Tayag E. C. and Lehmann J. C. (1999) Endothelin receptor subtype distribution in rat brain. J. neurol. Sci. (in press).
60. A receptor expression in human cerebrovascular smooth muscle cells. Br. J. Pharmac. 116:1995;2441-2446.
61. Zhang W.W., Badonic T., Hoog A., Jiang M.H., Ma K.C., Nie X.J., Olsson Y. Astrocytes in Alzheimer's disease express immunoreactivity to the vasoconstrictor endothelin-1. J. neurol. Sci. 122:1994;90-96.
62. Zola-Morgan S., Squire L.R., Rempel N.L., Clower R.P., Amaral D.G. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J. Neurosci. 12:1992;2582-2596.